Ashley Cordova, Chief Financial Officer at NovoCure Ltd (NVCR), sold 1,770 shares at $79.04 ($140K) on 2022-09-02, disclosed to the SEC on 2022-09-06.
Open-market sale of $140k NVCR by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $79.04 | 885 | $70K | 50.0% |
| 2 | $79.04 | 885 | $70K | 50.0% |
| Total | $79.04 avg | 1,770 | $140K | 100% |
| Filing → |
| NVCR | SELL | 2025-03-03 | $452K | — | Filing → |
| NVCR | SELL | 2024-08-05 | $14K | — | Filing → |
| NVCR | SELL | 2023-09-05 | $19K | — | Filing → |